Gang Chen, Jing Xu, Xiaoyu He, Yixin Yan, Linhui Hu, Zhenjiang Li. Genetic and clinical evidence supports HLA-DR+ CD8+ T cells as a favorable immune biomarker in acute myeloid leukemia. // Clinical Immunology. – DOI: 10.1016/j.clim.2026.110785. – URL: https://www.sciencedirect.com/science/article/pii/S1521661626001233?dgcid=rss_sd_all
Gang Chen, Jing Xu, Xiaoyu He, Yixin Yan, Linhui Hu, & Zhenjiang Li Genetic and clinical evidence supports HLA-DR+ CD8+ T cells as a favorable immune biomarker in acute myeloid leukemia. Clinical Immunology. https://doi.org/10.1016/j.clim.2026.110785
Gang Chen, et al. “Genetic and clinical evidence supports HLA-DR+ CD8+ T cells as a favorable immune biomarker in acute myeloid leukemia.” Clinical Immunology. doi:10.1016/j.clim.2026.110785.
@article{Chen,
title = {Genetic and clinical evidence supports HLA-DR+ CD8+ T cells as a favorable immune biomarker in acute myeloid leukemia},
author = {Chen, Gang and Xu, Jing and He, Xiaoyu and Yan, Yixin and Hu, Linhui and Li, Zhenjiang},
journal = {Clinical Immunology},
doi = {10.1016/j.clim.2026.110785},
url = {https://www.sciencedirect.com/science/article/pii/S1521661626001233?dgcid=rss_sd_all}
}